Medical Science Liaison — Obesity & Metabolic Health

Amgen Inc.; Oregon; Hybrid; USD 157,000 - 212,000; Full time

Benefits offered by this job

Total rewards plan

Flexible work models

Competitive benefits package

Job summary

Amgen is seeking a Medical Science Liaison for Obesity and Related Conditions in the White Plains NY area. This field-based role covers Poughkeepsie/Newburgh/White Plains/Yonkers and surrounding areas, reporting to an MSL Field Director.

The MSL will serve as a primary scientific resource to OLs and healthcare providers, executing Amgen's medical strategy and expanding the obesity portfolio with compliant scientific data.

Qualifications

• Doctorate degree.
• Master's degree and 3 years of Medical Affairs experience.
• Bachelor's degree and 5 years of Medical Affairs experience.
• Pharm.D., Ph.D., M.D. or D.O. (other doctoral degrees considered)
• 1+ years Medical Affairs experience
• 4 or more years in a medically related field, including 1 year focused on clinical practice, clinical research, or medical research.

Responsibilities

• Act as the primary scientific/clinical resource to Opinion Leaders (OLs), Population Health Decision Makers (PHDMs) and other healthcare providers.
• Execute Amgen Medical function and product strategy as led by MSL Leadership to improve patient outcomes.
• Engage with clinical investigators and sites in support of the obesity pipeline.
• Communicate scientific data of clinical value, outcomes, and economic data to PHDMs within assigned IDNs and other institutions.

Education

Doctorate degree

Master's degree with 3 years Medical Affairs experience

Bachelor's degree with 5 years Medical Affairs experience

Job description

Amgen is seeking a Medical Science Liaison for Obesity and Related Conditions in the White Plains NY area. This field-based role covers Poughkeepsie/Newburgh/White Plains/Yonkers and surrounding areas, reporting to an MSL Field Director.

The MSL will serve as a primary scientific resource to OLs and healthcare providers, executing Amgen's medical strategy and expanding the obesity portfolio with compliant scientific data.